Cellular Vehicles
Private Company
Total funding raised: $25M
Overview
Cellular Vehicles is a private, pre-clinical stage biotech founded in 2018 and based in Cambridge, Massachusetts. The company is building an integrated technology platform focused on automating and scaling the formulation and delivery of cell therapies, aiming to solve critical bottlenecks in the manufacturing process. While still early-stage with a small core team, it is positioning itself at the intersection of advanced therapy manufacturing and targeted drug delivery. The company appears to be pre-revenue and is likely funded by venture capital or grants, though specific investors are not disclosed on its website.
Technology Platform
Integrated platform combining microfluidics, robotics, and AI for automated formulation and dose preparation of cell-based therapies.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Cellular Vehicles competes in the cell therapy manufacturing tools space against large incumbents like Thermo Fisher Scientific and Danaher (Cytiva), as well as numerous startups focused on automation, closed systems, and process analytics. Differentiation will hinge on the seamless integration of microfluidics, robotics, and AI for the specific formulation challenge.